[1]
“JAK2V617F mutation detection in patients with clinical suspicion of myeloproliferative neoplasm without leukemic expression. Preliminary study”., ANALES, vol. 47, no. 2, pp. 41–49, Oct. 2026, doi: 10.18004/.